Since the PTEN R159K mutation has been found in numerous somatic human cancers, including glioma, melanoma and thyroid cancer [145], the consequent global deregulation of splicing might contribute to the oncogenic program triggered by the constitutive activation of the PI3K/AKT pathway. The gene discussed is AKT1; the disease is central nervous system cancer.